Shooli, H and Dadgar, H and Wáng, Y.-X.J and Vafaee, M.S and ashuk, S.R and Nemati, R and Jafari, E and Nabipour, I and Gholamrezanezhad, A and Assadi, M and Larvie, M (2019) An update on PET-based molecular imaging in neuro-oncology: Challenges and implementation for a precision medicine approach in cancer care. Quantitative Imaging in Medicine and Surgery, 9 (9). pp. 1597-1610. ISSN 22234292
Full text not available from this repository.Abstract
PET imaging using novel radiotracers show promises for tumor grading and molecular characterization through visualizing molecular and functional properties of the tumors. Application of PET tracers in brain neoplasm depends on both type of the neoplasm and the research or clinical significance required to be addressed. In clinical neuro-oncology, 18F-FDG is used mainly to differentiate tumor recurrence from radiation-induced necrosis, and novel PET agents show attractive imaging properties. Novel PET tracers can offer biologic information not visible via contrast-enhanced MRI or 18F-FDG PET. This review aims to provide an update on the complementary role of PET imaging in neuro-oncology both in research and clinical settings along with presenting interesting cases in this context.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | 68Ga-DOTA-peptide،68Ga-labeled PSMA،Brain tumors،Magnetic resonance imaging (MRI)،Molecular imaging،Positron emission tomography (PET)،Precision medicine |
| Subjects: | WN Radiology . Diagnostic Imaging |
| Divisions: | Research Center > Persian Gulf Nuclear Medicine Research Center |
| Depositing User: | خدیجه شبانکاره |
| Date Deposited: | 02 Jan 2021 09:20 |
| Last Modified: | 02 Jan 2021 09:20 |
| URI: | http://eprints.bpums.ac.ir/id/eprint/9239 |
Actions (login required)
 |
View Item |
